ARLINGTON, Va. – National Association of Chain Drug Stores (NACDS) president and CEO Steven Anderson issued the following statement Tuesday:
“Words like ‘continuing resolution,’ ‘budget reconciliation,’ and ‘standalone bill’ are the words of Washington, DC. While all of these legislative vehicles are sorted out, one fact remains: pharmacy benefit manager (PBM) reform remains a long overdue need and the costs of inaction continue to ravage Americans, their pharmacies, and their communities.
“Every day, Americans are living with the acceleration of prescription drug price inflation and the closing of trusted and convenient pharmacies.At the hands of the PBM middlemen, nearly four pharmacies are closing each day – at an increasing rate. Americans have missed out on hundreds of millions of dollars of savings just since the last Congress ended. The costs of inaction on PBM reform are massive and they are growing, all while the PBMs redouble their revenue.
"Meanwhile, Congress has reforms ready to go – a sound package that was finalized last December. Americans need this win and it is time to deliver it to them. As Congress and the Administration figure out the legislative roadmap, PBM reform needs to get done without further needless delay.”
More information is available on a new NACDS fact sheet.
NACDS: A legislative vehicle must include PBM reform; inaction is costing Americans
Nearly four pharmacies are closing every day; Americans are missing out on hundreds of millions in savings just since the last Congress' end.
Latest
Aetna reduces claims processing time by more than 20% with AI to improve care experience
The platform responds directly to provider feedback. In Aetna's recent provider survey, reducing administrative burden and simplifying insurance processes ranked among the highest priorities.
Cencora Community Pharmacy Unit unveils new leadership structure
Hohman and Weber to focus on innovation, performance.
Buying outside the pharmacy: 45% of peptide users who source from social media have visited the ER
A new Sunlight survey of 1,000 U.S. peptide users finds that gray-market buyers visit the ER at 3x the rate of all peptide users. Three in four of these buyers have told their doctor about their peptide use, but the doctor never sees what was bought on social media.
CVS sues to overturn Tennessee PBM law
The legal action challenges the statute's constitutionality.